Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Gastroenterology
|
March 22, 2021
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer
Akira Inoue, Frederick S Robinson, Rosalba Minelli, et al.
Nature
|
March 29, 2019
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer
Wantong Yao, Johnathon L Rose, Wei Wang, et al.
Nature Communications
|
February 8, 2024
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma
Natthakan Thongon, Feiyang Ma, Natalia Baran, et al.
Cell Reports
|
June 21, 2016
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer
Alessandro Carugo, Giannicola Genovese, Sahil Seth, et al.
Cancer Cell
|
February 1, 2026
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
Alessandro Carugo, Rosalba Minelli, Luigi Sapio, et al.
Nature Cancer
|
November 21, 2022
Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells
Christopher J Halbrook, Galloway Thurston, Seth Boyer, et al.
Nature Biotechnology
|
June 13, 2022
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
Shaolong Cao, Jennifer R Wang, Shuangxi Ji, et al.
Science Advances
|
March 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancer
I-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang, et al.
Nature
|
February 9, 2017
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
Giannicola Genovese, Alessandro Carugo, James Tepper, et al.
Cancer Research
|
April 6, 2026
DPY30 is an epigenetic decoupler linking replication stress to immunoediting in pancreatic cancer
Francesca Citron, Luca Cecchetto, Elisabetta Granato, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Gastroenterology
|
March 22, 2021
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer
Akira Inoue, Frederick S Robinson, Rosalba Minelli, et al.
Nature
|
March 29, 2019
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer
Wantong Yao, Johnathon L Rose, Wei Wang, et al.
Nature Communications
|
February 8, 2024
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma
Natthakan Thongon, Feiyang Ma, Natalia Baran, et al.
Cell Reports
|
June 21, 2016
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer
Alessandro Carugo, Giannicola Genovese, Sahil Seth, et al.
Cancer Cell
|
February 1, 2026
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
Alessandro Carugo, Rosalba Minelli, Luigi Sapio, et al.
Nature Cancer
|
November 21, 2022
Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells
Christopher J Halbrook, Galloway Thurston, Seth Boyer, et al.
Nature Biotechnology
|
June 13, 2022
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
Shaolong Cao, Jennifer R Wang, Shuangxi Ji, et al.
Science Advances
|
March 13, 2024
Clonal dominance defines metastatic dissemination in pancreatic cancer
I-Lin Ho, Chieh-Yuan Li, Fuchenchu Wang, et al.
Nature
|
February 9, 2017
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
Giannicola Genovese, Alessandro Carugo, James Tepper, et al.
Cancer Research
|
April 6, 2026
DPY30 is an epigenetic decoupler linking replication stress to immunoediting in pancreatic cancer
Francesca Citron, Luca Cecchetto, Elisabetta Granato, et al.
Page
of 6